Treatment of Liver Metastases in Patients with Digestive Neuroendocrine Tumors
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 16 (10) , 1981-1992
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Gut, 2011
- The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statementVirchows Archiv, 2010
- 90Y-Edotreotide for Metastatic Carcinoid Refractory to OctreotideJournal of Clinical Oncology, 2010
- O 6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine TumorsClinical Cancer Research, 2008
- Efficacy of RAD001 (Everolimus) and Octreotide LAR in Advanced Low- to Intermediate-Grade Neuroendocrine Tumors: Results of a Phase II StudyJournal of Clinical Oncology, 2008
- Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumoursBritish Journal of Cancer, 2006
- A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomasBritish Journal of Cancer, 2006
- Development of a disease-specific quality of life questionnaire module for patients with gastrointestinal neuroendocrine tumoursEuropean Journal of Cancer, 2006
- The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinomaEuropean Journal of Cancer, 2004
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993